title: Open Lab as a source of hits and leads against tuberculosis, malaria and kinetoplastid diseases.
authors.affiliation: Department of Diseases of the Developing World, GlaxoSmithKline, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
authors.forename: Lluís
authors.initials: L
authors.lastname: Ballell
authors.affiliation: Department of Diseases of the Developing World, GlaxoSmithKline, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
authors.forename: Mike
authors.initials: M
authors.lastname: Strange
authors.affiliation: Department of Diseases of the Developing World, GlaxoSmithKline, Parque Tecnológico de Madrid, Calle de Severo Ochoa, 2, 28760 Tres Cantos, Madrid, Spain.
authors.forename: Nicholas
authors.initials: N
authors.lastname: Cammack
authors.affiliation: Division of Biological Chemistry and Drug Discovery, College of Life Sciences, University of Dundee, Dundee DD1 5EH, UK.
authors.forename: Alan H
authors.initials: AH
authors.lastname: Fairlamb
authors.affiliation: Department of Medicine, University of Cambridge, Cambridge CB2 0SP, UK.
authors.forename: Leszek
authors.initials: L
authors.lastname: Borysiewicz
mesh_terms: D000818:Animals; D003906:Developing Countries; D055808:Drug Discovery / Q000639:trends*; D005582:Foundations / Q000639:trends*; D006801:Humans; D008288:Malaria / Q000188:drug therapy*; D058069:Neglected Diseases / Q000188:drug therapy*; D014376:Tuberculosis / Q000188:drug therapy*